Biohaven drug wins U.S. FDA approval for use in relieving migraine headaches

The U.S. Food and Drug Administration on Thursday approved Biohaven Pharmaceutical Holding Co Ltd's oral pill for relieving pain after the onset of migraine headaches, the drug developer said.

from Reuters: Health https://ift.tt/2I4VAoa
via IFTTT

• Tweet
• Share
• Share
• Share
• Share